TNF and COVID-19: However, patients with severe COVID-19, for example, patients with hypoxic respiratory failure, develop hyperinflammation with the release of pro-inflammatory cytokines, such as interleukin (IL)-1, IL-6, IL-8, or Tumor necrosis factor alpha (TNFα).